Sevelamer Hydrochloride Tablet, Film Coated
Product Images NDC 0904-7209

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 0904-7209). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

800mg Carton Label (0500034d 458c 42c5 918d 9acd22f0c28b 00)

800mg Carton Label (0500034d 458c 42c5 918d 9acd22f0c28b 00)
Sevelamer Hydrochloride 800 mg film-coated tablets unit dose packaging label by Major Pharmaceuticals. The label shows the NDC 0904-7209-06 and indicates a package count of 50 tablets (5x10). It includes dosage information, storage instructions, and a barcode. The label states Rx only and notes this is an Institutional Use Only unit dose package.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure diagram showing the polymeric composition of sevelamer hydrochloride, indicating repeating units with amine groups complexed with hydrochloride (NH2•nHCl) and a central alcohol (OH) group in one of the monomers.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A line graph comparing the percentage of patients with a reduction in serum phosphorus of at least a given level between sevelamer hydrochloride and an active control. The x-axis shows reduction in serum phosphorus in mg/dL, ranging from -4 to 8, and the y-axis shows percentage of patients. The graph highlights areas of worsened increase and improved reduction from baseline.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph comparing phosphorus change from baseline over 52 study weeks between sevelamer hydrochloride and an active control. The x-axis represents study weeks from 0 to 52, and the y-axis shows phosphorus change from baseline ranging from -5 to 2. Two lines, one with black circles for sevelamer hydrochloride and one with red squares for active control, display trends over time.*
FDA Label Image
Glenmark-logo (Glenmark Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.